Anti-Infective Drugs Advisory Committee Meeting; Amendment of Notice

Riepilogo

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Anti-Infective Drugs Advisory Committee meeting. This meeting was announced in the Federal Register of February 3, 1998 (63 FR 5562). The amendment is being made to reflect a change in the agenda for the February 19, 1998, meeting day. An additional indication for use in the treatment of infections caused by Staphylococcus aureus will also be discussed. There are no other changes. This amendment will be announced at the beginning of the open portion of the meeting.